http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8899213

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't
endingPage 1166
issn 1532-1827
0007-0920
issueIdentifier 9
pageRange 1161-1166
publicationName British Journal of Cancer
startingPage 1161
bibliographicCitation Campone M, Cortes-Funes H, Vorobiof D, Martin M, Slabber CF, Ciruelos E, Bourbouloux E, Mendiola C, Delgado FM, Colin C, Aslanis V, Fumoleau P. Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy. British Journal of Cancer. 2006 Oct 10;95(9):1161–6. doi: 10.1038/sj.bjc.6603347.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10a630431e59fd6c4912b99d6e8b4b93
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e940490f1ad50295d26c5626ed5a0bf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f97f802bd26c0da95765711acc526f7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7dc4fafe15bc02d761bc06719b0cb8b1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0d64e2965c22ff853b1a05e64c17e5c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e4db00c03a0c519af7a3f3848a09523
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b5bd999a8ee4fc1c6f426003334dd6b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b8f68c1a0946f58fdb5256c877aae80
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a7ec286ce34f7c6845caf4ce10d9022
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7c64a2e6fbff009e8988219b86e9c5c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b83c7b6e39e23bffc6143168da95b88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7751196f86ba665fea9e4bb910b17e9
date 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/17031408
https://doi.org/10.1038/sj.bjc.6603347
https://pubmed.ncbi.nlm.nih.gov/PMC2360552
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/1532-1827
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy
discusses http://id.nlm.nih.gov/mesh/M0002922
http://id.nlm.nih.gov/mesh/M0028312
http://id.nlm.nih.gov/mesh/M0022672
http://id.nlm.nih.gov/mesh/M0288082
http://id.nlm.nih.gov/mesh/M0215357
http://id.nlm.nih.gov/mesh/M0443608
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21874242
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7ed75134b36b0e173fb44798462e4e66
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9d7fe60f25abdf582afc7cdca238bde8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157688
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d445950097f904f6fd5b28f1b37c3abf
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118218024
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10629256

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135873354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129430288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249215032

Total number of triples: 67.